Fredrik Erlandsson

Company: Vifor Pharma

Job title: Vice President, Head of Global Clinical Development

Seminars:

Using Calciphylaxis, a Rare & Severe Condition in Patients on Dialysis, as a Model Disease for Vascular Calcification in Kidney Disease 5:00 pm

Investigating calciphylaxis, a rare disorder driven by severe vascular calcification resulting in wounds, infections, and often mortality, among dialysis patients Evaluating calciphylaxis as a model condition to evaluate novel treatment approaches Understanding the mechanism and development of SNF472, a vascular calcification inhibitor in development for calciphylaxisRead more

day: Day Two

Panel Discussion: Streamlining or Impeding Clinical Success? Defining the Balance Between Precision Medicine & Patient Exclusion 12:30 pm

How far should we be selecting patients that are fast progressors to streamline understanding of efficacy? Segmenting patients in rare kidney diseases: how homogeneous does the patient population need to be in a small patient population? Considering impact of precision medicine on commercial viability of drugs and ethical implications of excluding patients from trialsRead more

day: Day Two